Kobophenol A
|  | |||
| Names | |||
|---|---|---|---|
| Preferred IUPAC name (2S,2′R,3S,3′R)-3′-(3,5-Dihydroxyphenyl)-4-[(2S,3S,4R,5S)-4-(3,5-dihydroxyphenyl)-2,5-bis(4-hydroxyphenyl)oxolan-3-yl]-2,2′-bis(4-hydroxyphenyl)-2,2′,3,3′-tetrahydro[3,4′-bi-1-benzofuran]-6,6′-diol | |||
| Other names kob A | |||
| Identifiers | |||
| 3D model (JSmol) | |||
| ChemSpider | |||
| PubChem CID | |||
| CompTox Dashboard (EPA) | |||
| 
 | |||
| 
 | |||
| Properties | |||
| C56H44O13 | |||
| Molar mass | 924.94 g/mol | ||
| Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). Infobox references | |||
Kobophenol A is a stilbenoid. It is a tetramer of resveratrol. It can be isolated from Caragana chamlagu, from Caragana sinica and from Carex folliculata seeds.
The molecule shows a 2,3,4,5-tetraaryltetrahydrofuran skeleton.
It has been shown to inhibit acetylcholinesterase.
Acid-catalyzed epimerization of kobophenol A to carasinol B can be performed in vitro.